TuHURA BIOSCIENCES, INC./NV Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure
TuHURA BIOSCIENCES, INC./NV (HURA) reported Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure of $65.00 thousand for the 12-month period ending 2024-06-30, per its 10-K filed 2024-10-07.
Financial Statements › Notes
us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure · last filed 2024-10-07
- TuHURA BIOSCIENCES, INC./NV concentration risk, credit risk, financial instrument, maximum exposure for fiscal 2024 was $65.00K, a 441.67% increase from fiscal 2023.
- TuHURA BIOSCIENCES, INC./NV concentration risk, credit risk, financial instrument, maximum exposure for fiscal 2023 was $12.00K, a 36.84% decline from fiscal 2022.
- TuHURA BIOSCIENCES, INC./NV concentration risk, credit risk, financial instrument, maximum exposure for fiscal 2022 was $19.00K, a 137.50% increase from fiscal 2021.
- TuHURA BIOSCIENCES, INC./NV concentration risk, credit risk, financial instrument, maximum exposure for fiscal 2021 was $8.00K, a 14.90% decline from fiscal 2020.
| Period end | Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure 12 month |
|---|---|
| 2024-06-30 | $65.00K 10-K · filed 2024-10-07 |
| 2023-06-30 | $12.00K 10-K · filed 2023-09-18 |
| 2022-06-30 | $19.00K 10-K · filed 2022-09-27 |
| 2021-06-30 | $8.00K 10-K · filed 2021-09-28 |
| 2020-06-30 | $9.40K 10-K · filed 2020-09-18 |
| 2019-06-30 | $26.19K 10-K · filed 2019-09-09 |
| 2018-06-30 | $39.52K 8-K · filed 2019-06-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |